Sex hormones regulate neuromuscular junction structure, plasticity, and disease vulnerability

The neuromuscular junction (NMJ) is a highly specialized synapse that enables efficient communication between motor neurons and skeletal muscle fibers. Its structural integrity is essential for voluntary movement, yet the NMJ is not static and undergoes continuous remodelling in response to physiological and pathological challenges. Emerging evidence highlights sex and hormonal regulation as critical determinants of NMJ plasticity. Estrogen, testosterone, and progesterone influence neurotransmitter release, postsynaptic receptor clustering, neurotrophic signalling, and glial support. Their fluctuations across puberty, reproductive age, menopause, and aging shape NMJ vulnerability and resilience, offering mechanistic insight into sex-biased patterns of neuromuscular aging and disease. Clinical observations in disorders such as myasthenia gravis and amyotrophic lateral sclerosis reveal sex-linked differences in onset, progression, and therapeutic outcomes, further underscoring the role of endocrine status. Translational strategies are beginning to exploit these mechanisms. Hormone replacement therapy, pharmacological synaptic stabilizers, and lifestyle interventions such as exercise, nutrition, and sleep regulation show potential to modulate NMJ health. In parallel, personalized and sex-specific medicine frameworks incorporating genomics, biomarkers, and endocrine profiling hold promise for precision-based approaches. Despite these advances, significant knowledge gaps remain. Experimental systems underrepresent female biology, clinical trials rarely stratify by sex or hormonal status, and systems biology approaches are only beginning to uncover sex-dependent regulatory networks. Addressing these gaps will require interdisciplinary research integrating endocrinology, neuroscience, and systems medicine. A deeper understanding of sex and hormonal regulation at the NMJ may ultimately enable individualized interventions that preserve synaptic function across aging, disease, and regeneration.

Authors

Institutions

Publication Details

Journal
Discover Neuroscience
Published
2026-02-18
DOI
https://doi.org/10.1186/s13064-026-00241-0
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex hormones regulate neuromuscular junction structure, plasticity, and disease vulnerability

Rizwan Qaisar, Asima Karim, Firdos Ahmad
Discover Neuroscience
Amyotrophic Lateral Sclerosis Research
article

Sex hormones regulate neuromuscular junction structure, plasticity, and disease vulnerability

Rizwan Qaisar, Asima Karim, Firdos Ahmad
article en

Abstract

The neuromuscular junction (NMJ) is a highly specialized synapse that enables efficient communication between motor neurons and skeletal muscle fibers. Its structural integrity is essential for voluntary movement, yet the NMJ is not static and undergoes continuous remodelling in response to physiological and pathological challenges. Emerging evidence highlights sex and hormonal regulation as critical determinants of NMJ plasticity. Estrogen, testosterone, and progesterone influence neurotransmitter release, postsynaptic receptor clustering, neurotrophic signalling, and glial support. Their fluctuations across puberty, reproductive age, menopause, and aging shape NMJ vulnerability and resilience, offering mechanistic insight into sex-biased patterns of neuromuscular aging and disease. Clinical observations in disorders such as myasthenia gravis and amyotrophic lateral sclerosis reveal sex-linked differences in onset, progression, and therapeutic outcomes, further underscoring the role of endocrine status. Translational strategies are beginning to exploit these mechanisms. Hormone replacement therapy, pharmacological synaptic stabilizers, and lifestyle interventions such as exercise, nutrition, and sleep regulation show potential to modulate NMJ health. In parallel, personalized and sex-specific medicine frameworks incorporating genomics, biomarkers, and endocrine profiling hold promise for precision-based approaches. Despite these advances, significant knowledge gaps remain. Experimental systems underrepresent female biology, clinical trials rarely stratify by sex or hormonal status, and systems biology approaches are only beginning to uncover sex-dependent regulatory networks. Addressing these gaps will require interdisciplinary research integrating endocrinology, neuroscience, and systems medicine. A deeper understanding of sex and hormonal regulation at the NMJ may ultimately enable individualized interventions that preserve synaptic function across aging, disease, and regeneration.

Discover NeuroscienceVol. 21(1)
University of Sharjah (AE)
Openalex Percentile: Top 55%
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.